We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Complying With License, MedImmune Loses Case

Law360 (October 20, 2005, 12:00 AM EDT) -- Biotechnology company MedImmune Inc. thwarted its own efforts at invalidating a patent held by rival Genentech Inc. because it followed through on a license agreement, according to a ruling affirmed by the Federal Circuit.

MedImmune sued Genentech in April 2003 in U.S. District Court for the Central District of California, seeking declaratory judgment that a newly-issued patent for using cell cultures to manufacture human antibodies was unenforceable. Genentech was seeking royalties on the patent, a continuation of the patent already licensed to MedImmune.

The lower court...
To view the full article, register now.